THE COUNCIL OF THE QUEENSLAND INSTITUTE OF MEDICAL RESEARCH
Total Received
$5.0M
Total Awards
7
Last Updated
Sep 12, 2025
Yearly Funding Trend
$4.6M24
$440K25
Top 7 Awards to THE COUNCIL OF THE QUEENSLAND INSTITUTE OF MEDICAL RESEARCH
Largest individual federal awards on record for this recipient, ranked by obligated amount. Data through September 12, 2025.
| Award | Awarding Agency | Program | Place | FY | Obligation |
|---|---|---|---|---|---|
ASST_NON_HT94252410885_097 THE NOSE KNOWS: HARNESSING HUMAN OLFACTORY CELLS TO IDENTIFY BIOMARKERS OF NONMOTOR CHANGES IN PARKINSON'S DISEASE | Department of Defense Defense Health Agency | 12.420 MILITARY MEDICAL RESEARCH AND DEVELOPMENT | — | 2024 | $1,173,445 |
ASST_NON_R01MH136157_075 2/3 EATING DISORDERS GENETICS INITIATIVE 2 - PROJECT SUMMARY WE PROPOSE THE EATING DISORDERS GENETICS INITIATIVE 2 (EDGI2), A NEW COLLABORATIVE R01 IN RESPONSE TO PAR- 23-050 CLIN… | Department of Health and Human Services National Institutes of Health | 93.242 MENTAL HEALTH RESEARCH GRANTS | — | 2024 | $939,021 |
ASST_NON_W911SR2210003_097 ADD INCREMENTAL FUNDING TO ONGOING R&D EFFORT BY ADDING $298,769.64. | Department of Defense Department of the Army | 12.355 PEST MANAGEMENT AND VECTOR CONTROL RESEARCH | — | 2024 | $886,301 |
ASST_NON_W81XWH2210714_097 ADVANCED PATIENT-DERIVED MICROGLIA ASSAY FOR PRECLINICAL AND CLINICAL TRIAL DRUG VALIDATION EXTEND THE PERIOD OF PERFORMANCE 1. PER SECTION 711 OF THE NATIONAL DEFENSE AUTHORIZATI… | Department of Defense Defense Health Agency | 12.420 MILITARY MEDICAL RESEARCH AND DEVELOPMENT | — | 2024 | $659,568 |
ASST_NON_HT94252410037_097 PROOF-OF-CONCEPT STUDIES FOR A NOVEL IMMUNOTHERAPY FOR TRIPLE-NEGATIVE BREAST CANCER AND COMPANION DIAGNOSTIC | Department of Defense Defense Health Agency | 12.420 MILITARY MEDICAL RESEARCH AND DEVELOPMENT | — | 2024 | $477,231 |
ASST_NON_HT94252310764_097 USING GENETICS TO IDENTIFY NEW ENDOMETRIAL CANCER THERAPEUTICS EXTEND THE PERIOD OF PERFORMANCE | Department of Defense Defense Health Agency | 12.420 MILITARY MEDICAL RESEARCH AND DEVELOPMENT | — | 2025 | $439,692 |
ASST_NON_W81XWH2210427_097 TARGETING CEP55 IN TRIPLE-NEGATIVE BREAST CANCER. EXTENDS THE POP BY 12 MONTHS. | Department of Defense Defense Health Agency | 12.420 MILITARY MEDICAL RESEARCH AND DEVELOPMENT | — | 2024 | $439,609 |
Top 7 awards shown, ranked by obligated amount. Dates reflect performance period; last-modified dates match USAspending.gov. Complete listings include all transaction history going back to FY2024.
Source: USAspending.gov · All Recipients